Article Details
Retrieved on: 2022-11-04 07:58:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
"We are developing AB-101 as a universal ADCC enhancer when combined with monoclonal antibodies and NK cell engagers,” said Dr. Fred Aslan, ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here